ABsize Inc. is a nanotechnology / nanomedicine company. Using its proprietary technology platform, Laser-induced Nanolization Technology (LiNTEC), ABsize is developing a novel nano-drug product pipeline, and partnering with pharma / biotech companies to developing their new products. LiNTEC is a non-thermal and non-contact physical process to nanolize poorly water-soluble molecules without chemical change, thereby increasing water solubility, improving bioavailability, and creating new formulations and delivery route.
Isamu Oh, Ph.D.,
LiNTEC inventor, professor of Osaka University; co-founder of Hanaphi and Neubrex.
CJ Wang, Ph.D.,
former VP Bus Dev of VIVUS, Abmaxis and TaiGen Biotech; VP Marketing and Bus Dev of Cellomics; Dir. Licensing & Acquisition, Packard Bioscience.
|Company Name||ABsize Inc.|
|Foundation||Jan 10th, 2007|
|Our Office||10 S. Third St, 3rd Floor,
San Jose CA, 95113, USA
|S-cube 324, 130-42, Nagasone-cho, Kita-ku, Sakai-shi, Osaka, 591-8025, Japan
|Kobe office||2-2, Minatojima Minamimachi, Chuo-ku, Kobe 650-0047, Japan
|CEO||CJ Wang, Ph.D.|
|Founder/CTO||Isamu Oh. Ph.D.|
|Director||CJ Wang Ph.D.|
|Scientific Officer||Dr. Hiroshi Masuhara Professor
Emeritus of Osaka Univeristy
Dr. Hideki Yoshikawa Chairman and Professor, Department of Orthopaedics, Osaka University Graduate School of Medicine
Dr. Noriyuki Tsumaki, M.D. Osaka University Graduate School of Medicine
|Business Supporters||Kirkpatrick & Lockhart
Preston Gates Ellis LLP
Matsumoto & Associates
|Current Investor VCs||Nippon Venture Capital, Future Venture Capital, Angel Capital, and Resona Capital, Co., Ltd.|